WASHINGTON, Jan 17 (Reuters) - U.S. Health and Human Services Secretary Xavier Becerra said on Friday the government will try to negotiate better prices for the 15 drugs targeted for Medicare price negotiations for 2027 because they are too expensive.
"The reason we're going to negotiate for lower prices of these 15 drugs, the way we did last year for the 10 most expensive drugs, is because the facts show that not only do they work, but those drugs are too expensive and should be lowered in price," Becerra said in an interview with CNN.
(Reporting by Doina Chiacu; editing by Christina Fincher)
((doina.chiacu@thomsonreuters.com; 202-898-8322;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.